CytoMed Therapeutics Limited (GDTC)
$0.89-5.32%Close
BUYRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $11M
- Beta
- 0.05
- P/E (TTM)
- -2.59
- Short % float
- 0.49%
- Days to cover
- 1.1
- SI change
- +372.4%
- 1W
- -3.26%
- 1M
- +9.88%
- vs SPY 1W
- -4.42%
- vs SPY 1M
- +6.88%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on GDTC?
- LOPJLB’s latest quantitative signal on CytoMed Therapeutics Limited (GDTC) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is GDTC in?
- CytoMed Therapeutics Limited (GDTC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does CytoMed Therapeutics Limited (GDTC) do?
- CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR)…